Tag: ISC

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes of the device, 80.2% patients in the study achieved mTICI 2b–3 grade revascularisation in the target vessel. The results were presented at International Stroke Conference (ISC; 24–26 January 2018, Los Angeles, USA)

ARISE II results show two-thirds of ischaemic stroke patients return to...

EmboTrap (Neuravi/Johnson and Johnson’s Cerenovus) achieved a high reperfusion rate among acute ischaemic stroke patients with large vessel occlusion. With three, or fewer, passes...

New ischaemic stroke guidelines widen mechanical thrombectomy window to 24 hours...

The American Heart Association and American Stroke Association released updated ischaemic stroke guidelines that were published in Stroke, and released during the International Stroke...

“Aspiration first” approach with Penumbra system demonstrates favourable outcomes for acute...

Penumbra announced results of the company-sponsored PROMISE study, demonstrating real-world safety and efficacy of the Penumbra system with ACE 68 and ACE64 reperfusion catheters...

Hydrogel coils beat bare platinum in comparison study

The GREAT randomised controlled trial has confirmed that better outcomes can be achieved with hydrogel coils compared to bare platinum coils for the treatment...

Bleeding stroke survivors at higher risk of depression, dementia

People who survive brain bleeds are at significantly higher risk of later developing depression and dementia, according to research presented at the American Stroke...